Story Poster

BREAKING: Georgia Bulldogs Ranked No. 1: Kirby, Dawgs Shove Saban's Bama Aside

September 11, 2022
8,600

DON’T MISS OUT: Get our insider newsletter today!

ATHENS - Kirby Smart and the Georgia Bulldogs pushed Nick Saban’s Alabama Crimson Tide out of the No. 1 spot in college football after the weekend. 

No. 2 Alabama survived at Texas over the weekend - needing a game-winning drive led by Bryce Young in the final moments of the game. Alabama kicked a FG to win the game. No. 1 Georgia’s 33-0 win over Samford coupled with its destruction of No. 11 Oregon in Atlanta in week one was enough to move the Dawgs back to the top spot. 

Georgia was ranked No. 1 in the AP poll nine of the 15 weeks in 2021. Alabama was at the top the other six weekends in 2021. The last time a team other than the two SEC powers was ranked No. 1 was 2020 Clemson the week the Tigers lost at Notre Dame in November that year.



Celebrate Georgia's 2021 NATIONAL TITLE


Check out DAWGSTRUCTION NOW!



Georgia and Alabama are not scheduled to play one another in the regular season. They could only matchup in the SEC Championship or College Football Playoff. 

Georgia travels to South Carolina this weekend to take on Shane Beamer and the Gamecocks. According to FanDuel, the Bulldogs are 24.5-point favorites to beat the Gamecocks on the road. Alabama hosts Louisiana-Monroe before starting SEC play against Vanderbilt on September 24.

This is the fourth time Kirby’s program has reached the No. 1 spot in rankings. That first happened in the 2017 season in November. A season ago the Dawgs took over the top spot after Alabama lost on the road to Texas A&M, and recaptured the No. 1 spot after dismantling the Tide in the College Football Playoff National Championship Game in Indianapolis. 

Georgia was ranked No. 3 coming into the 2022 season, but tight wins for both Bama and Ohio State have elevated the Dawgs to the top of the weekly rankings. 

 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.